CellBiotech's Duolac: CBT Probiotic Shown to Improve Chronic Kidney Disease Mechanism
Predicted impact: Low
Probiotic mechanism research; early-stage with no disclosed financial impact.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.